Mirati Therapeutics reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 38.7B 2.18B
Astellas Pharma 4503:JP JPY 288B 30.1B
AstraZeneca AZN:LN USD 29.3B 229M
Bayer BAYN:GR EUR 44.79B 157M
Biocryst Pharmaceuticals BCRX:US USD 713.65M 91.47M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Eisai 4523:JP JPY 94.91B 8M
Eli Lilly And LLY:US USD 15.89B 925.4M
GlaxoSmithKline GSK:LN GBP 22.12B 4M
IONIS PHARMACEUT IONS:US USD 1.25B 1.34M
Moderna Inc MRNA:US USD 1.15B 384M
Novartis NOVN:VX USD 28.44B 2.59B
Puma Biotechnology PBYI:US USD 97.99M 312K
Roche Holding ROG:VX 27.75B 3.45B
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Takeda 4502:JP JPY 4.74T 134.39B
YTE INCY:US USD 33.59M 605K